Interactions of hematopoietic progenitor cells (HPC) with bone marrow stroma, mediated by adhesion molecules, are assumed to be critically important to the regulation of hematopoiesis. However, the specific roles of individual adhesion molecules involved in these interactions are poorly understood. Here, a monoclonal antibody, MEM-59, recognizing CD43, an adhesion molecule highly expressed on HPC, is shown to induce apoptosis in this cell population. This process operates at the single- cell level, and its initiation requires crosslinking of surface CD43 and the presence of cytokines. In contrast to HPC, more differentiated cells originating from this primitive cell population, as well as peripheral lymphocytes, do not undergo apoptosis in response to the CD43-mediated stimulation. Thus, CD43 may function as a negative regulator of early hematopoietic events, delivering a signal for apoptosis of HPC.
Skip Nav Destination
ARTICLES|
July 15, 1995
Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD43, the major sialoglycoprotein of leukocytes
V Bazil,
V Bazil
Research Department, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
J Brandt,
J Brandt
Research Department, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
A Tsukamoto,
A Tsukamoto
Research Department, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
R Hoffman
R Hoffman
Research Department, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
Blood (1995) 86 (2): 502–511.
Citation
V Bazil, J Brandt, A Tsukamoto, R Hoffman; Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD43, the major sialoglycoprotein of leukocytes. Blood 1995; 86 (2): 502–511. doi: https://doi.org/10.1182/blood.V86.2.502.bloodjournal862502
Download citation file:
July 15 1995
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal